Medicinal Products Availability
Seanad Éireann — 2021-01-26
============================================================

Joe O'Reilly (FG), Labour Panel

I am encouraged by this paragraph in the Minister of State's reply:
At that time the drugs group made a positive recommendation for reimbursement to the HSE executive management team. This was in the context of the recognised unmet need, the clinical evidence, the cost-effectiveness evidence and the resources available to the HSE.
That was in February 2020. I ask the Minister of State if he could arrange, through the Department, for me to get a note specific to this recommendation regarding when it will be implemented and when Duodopa will be available to patients. In the same context, I also ask the Minister of State to get me a brief on deep brain stimulation as a parallel treatment for another 5% of people. I look forward to the Minister of State's response.

---

Source: Houses of the Oireachtas. Licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). The Official Report is revised after first publication; the fetch timestamp below identifies the version quoted.

Record URI: https://data.oireachtas.ie/akn/ie/debateRecord/seanad/2021-01-26/debate/main
Retrieved: 2026-08-14T04:49:00+00:00
Sitting date: 2021-01-26